Momentum Stocks: Goldcorp Inc. (NYSE:GG), Tesla Motors Inc (NASDAQ:TSLA), Ford Motor Company (NYSE:F), Epizyme, Inc. (NASDAQ:EPZM), Yingli Green Energy Holding Co. (NYSE:YGE)

Goldcorp Inc. (NYSE:GG) belongs to Basic Materials sector. Its net profit margin is -66.00% and weekly performance is -2.16%. On last trading day company shares ended up $16.34. Goldcorp Inc. (NYSE:GG) distance from 50-day simple moving average (SMA50) is -6.62%. Goldcorp Inc. (NYSE:GG) announced a cash dividend payment of $0.05 per share is scheduled to be paid on July 24, 2015. Shareholders who purchased GG prior to the ex-dividend date are eligible for the cash dividend payment. This marks the 31st quarter that GG has paid the same dividend. At the current stock price of $16.44, the dividend yield is 3.65%.

Tesla Motors Inc (NASDAQ:TSLA) shares increased 1.16% in last trading session and ended the day at $262.16. TSLA Gross Margin is 28.00% and its return on assets is -8.00%. Tesla Motors Inc (NASDAQ:TSLA) quarterly performance is 24.97%. On 3 July, Tesla Motors Inc (NASDAQ:TSLA) is planning to open a sales and service center in Jacksonville for its all-electric cars.

On 13 July, Ford Motor Company (NYSE:F) shares increased 1.10% and was closed at $14.64. F EPS growth in last 5 year was -1.40%. Ford Motor Company (NYSE:F) year to date (YTD) performance is -3.69%. On 2 July, Ford Motor Company (NYSE:F) is recalling 432,000 Focus, C-Max and Escape vehicles because of a software problem that could keep their engines running after drivers try to shut them down.

Epizyme, Inc. (NASDAQ:EPZM) ended the last trading day at $24.21. Company weekly volatility is calculated as 5.99% and price to cash ratio as 4.08. Epizyme, Inc. (NASDAQ:EPZM) showed a weekly performance of 1.72%. Epizyme, Inc. (NASDAQ:EPZM) announced that updated data from the phase 1 portion of its ongoing phase 1/2 study of tazemetostat will be presented during the European Cancer Congress 2015, hosted by the European Society of Medical Oncology (ESMO), to be held in Vienna, Austria, September 25-28, 2015. Tazemetostat is a first-in-class EZH2 inhibitor that Epizyme is currently studying in patients with relapsed or refractory B-cell non-Hodgkin lymphomas (NHL) and advanced solid tumors, including INI1-deficient tumors.

Yingli Green Energy Holding Co. Ltd. (NYSE:YGE) shares increased 1.01% in last trading session and ended the day at $1.00. YGE Gross Margin is 16.90% and its return on assets is -4.80%. Yingli Green Energy Holding Co. Ltd. (NYSE:YGE) quarterly performance is -51.22%.On 30 June, Yingli Green Energy Holding Co. Ltd. (NYSE:YGE) announced that it completed a bond financing RMB 20 million yuan (USD $3.2 million) for a 4 megawatt (MW) solar project. Yingli’s financing partners for the project are Tianjin Xinhai Financial Leasing Co., Ltd. (Xinhai Leasing) and Principal Shield (Xiamen) Financial Technical Service Co., Ltd. The project bonds are now available for the Chinese public to invest in online at, the China-based Internet finance firm to offer P2B (person-to-business) online financial products, including loans and wealth management tools.

Leave a Reply

Your email address will not be published. Required fields are marked *